Baby wash does not damage baby's skin barrier function, study finds
2013-02-19
(Press-News.org) The findings by academics at The University of Manchester, published in the Journal of Obstetric, Gynecologic and Neonatal Nursing, compared Johnson's Baby Top-to-Toe wash against plain bath water on 307 newborn babies over a four week period.
The findings challenge the current advice from the National Institute for Health and Clinical Excellence (NICE) guidelines, that baby wash should be avoided in the first 6 weeks after birth.
Newborn skin is different to adult skin. The skin barrier on newborn babies is less mature and likely to be more vulnerable to environmental threats. But the study found no difference in transepidermal water loss (TEWL), which indicates the amount of water that escapes from the skin, between newborns bathed in water alone or with the wash product. Skin hydration increased in the wash product group compared to water alone when a babies' hydration at two weeks was analysed.
Project lead Professor Dame Tina Lavender said this offered reassurance that the wash product was not affecting the infant's natural skin barrier integrity.
Professor Lavender, Professor of Midwifery at The University of Manchester, said: "Whilst internationally it has been accepted that appropriate cleansing practices are important, a dearth of good quality clinical trials has led to variations in baby skin care regimens. However, women can now be confident that using this specific baby cleansing product on newborn skin is equivalent to bathing in water alone.
"This trial adds to the existing but limited evidence in the area and provides healthcare professionals with the strongest level of evidence available to date. Therefore we should no longer base our practice on tradition and experience alone. We should share the evidence from this study with parents, so they are able to make their own informed choices."
This research follows another recently published study conducted by The University of Manchester in which the use of Johnson's Baby Extra Sensitive Wipes was found to be equivalent to the use of water and cotton wool in terms of skin hydration. Mums taking part in the study also reported nappy rash as being higher in the water and cotton wool group.
The findings from both studies should offer reassurance to parents who choose to use these particular baby cleansing products. "These results should provide healthcare professionals and parents with much needed evidence-based information giving them the option to support the skin care cleansing regime chosen by individual parents for their newborn babies," Professor Lavender added.
### END
ELSE PRESS RELEASES FROM THIS DATE:
2013-02-19
A new approach to bladder regeneration is capitalizing on the potential of two distinct cell populations harvested from a patient's healthy bone marrow, a new study reports.
The Northwestern Medicine® research, which will be published February 18 in the Proceedings of the National Academy of Sciences by lead author Arun K. Sharma, research assistant professor in urology at Northwestern University Feinberg School of Medicine and colleagues, is an alternative to contemporary tissue-engineering strategies. The bone marrow cells are being used to recreate the organ's smooth ...
2013-02-19
Cambridge, MA, February xx, 2013 – Eleven Biotherapeutics, a biopharmaceutical company creating novel and differentiated protein-based biotherapeutics, has published preclinical data in Proceedings of the National Academy of Sciences (PNAS) showing beneficial effects of EBI-005, the first rationally-designed topically administered IL-1 protein for the treatment of ocular diseases. In the paper entitled "Design of a superior cytokine antagonist for topical ophthalmic use," the scientists, including drug developers from Eleven Biotherapeutics and collaborators from Howard ...
2013-02-19
Hepatitis C virus (HCV) infection affects about 4.1 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e., NS5A) and causes the fastest viral decline (within 12 hours of treatment) ever seen with anti-HCV drugs. An interdisciplinary effort by mathematical modelers, clinicians and molecular virologists has revealed that daclatasvir has two main modes of action against ...
2013-02-19
SALT LAKE CITY, Feb. 19, 2013 – University of Utah researchers ran computer simulations to show that the snow-producing "lake effect" isn't always enough to cause heavy snowfall, but that mountains or other surrounding topography sometimes are necessary too.
The study is relevant not only to forecasting lake-effect storms near the Great Salt Lake, Sea of Japan, Black Sea and other mountainous regions, but also sheds light on how even gentle topography near the Great Lakes helps enhance lake-effect snowstorms, says the study's senior author, Jim Steenburgh, a professor ...
2013-02-19
OAK BROOK, Ill. – Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
"CCTA should be considered as an appropriate first- line test for patients with atypical chest pain and suspected but not confirmed coronary artery disease," said the study's lead author, Jonathon Leipsic, M.D., ...
2013-02-19
Researchers have determined that fibromyalgia prevalence is 2.1% of the general population in Germany. Results appearing in Arthritis Care & Research, a journal published by Wiley on behalf of the American College of Rheumatology (ACR), suggest that fibromyalgia is a spectrum disorder rather than a categorical illness. Additionally, a number of fibromyalgia cases in the general population satisfy proposed criteria for physical symptom disorder—the presence of one or more physical symptoms that impair function, which cannot be explained by another clinical or psychiatric ...
2013-02-19
The new coronavirus that has emerged in the Middle East is well-adapted to infecting humans but could potentially be treated with immunotherapy, according to a study to be published on February 19 in mBio®, the online open-access journal of the American Society for Microbiology. The study indicates that the virus HCoV-EMC can penetrate the lining of the passageways in the lung and evade the innate immune system as easily as a cold virus can, signs that HCoV-EMC is well-equipped for infecting human cells. The study also reveals that the virus is susceptible to treatment ...
2013-02-19
The advancement of women in leadership has fundamentally shaped the business landscape, and Stiletto Woman Media celebrates this evolving influence. The company's mission to empower women in business has flourished into an effort that cultivates leaders and contributes to the progression of business owners and independent professionals.
Stiletto Woman In Business Awards (SWIBA) is a nationally recognized comprehensive awards program that exclusively honors women in the micro business sector. Known for its influential reach, this initiative commemorates prolific leaders ...
2013-02-19
Joseph Spinella, international tenor sensation, performs a special music and magic show in Venice, Florida for 16 shows starting on March 7, 2013. Returning from his recording sessions with the Macedonian Radio Symphonic Orchestra, Spinella sings classic Neapolitan songs from his latest album and performs exhilarating magic illusions on-stage.
The show starts out with a spot-on impersonation of Luciano Pavarotti and goes into a quick-change to a Venetian gondola. He sings in this magnificent tenor voice and performs magic as his assistant comes on stage and then disappears ...
2013-02-19
Roderick Hubbard, long-time expert in the field of drug design, will deliver the keynote address at GTC's 7th Drug Design & Medicinal Chemistry Conference, to be held May 8-10, 2013 in Boston, MA.
Professor Hubbard, who divides his time between academic research at the York Structural Biology Laboratory and applied research at the pharmaceutical company Vernalis, has a unique and balanced perspective of drug discovery in both academia and industry. He will review recent developments in the field during his presentation, "Current Perspectives in Fragment-Based ...
LAST 30 PRESS RELEASES:
[Press-News.org] Baby wash does not damage baby's skin barrier function, study finds